Omkar Speciality Chemicals Limited (BSE code: 533317), one of the largest manufacturer and supplier of Speciality Chemicals and Intermediates for Chemical and Allied Industries, reported a robust growth in revenues and profit after tax for the quarter ended March 31, 2019.
The company saw an increase in net sales by an impressive 53.67% from Rs. 7.90 crores to Rs. 12.14 crores during the fourth quarter as against third quarter of the last fiscal year. The Loss after tax for the quarter ended March 31, 2019 stood at Rs 4.92 crores, as against Rs. 5.10 crores in the third quarter of the last fiscal year.
"Our gross margin witnessed a significant improvement during fourth quarter which stands at Rs. 5.22 crores resulting into an increase of 67.85% as against Rs.3.11 crores in the third quarter, of the las fiscal year. The improvement in our gross margin was on account of our focus on development of Next-Gen niche molecules with high EBITDA margins. This led to a noticeable improvement in our overall working capital cycle. Besides, our past R&D efforts have also helped us in reaping benefits, as compared to last couple of quarters," said Mr. Rishikesh Herlekar, Whole-time Director and CFO of the Company.
"Our EBITDA (before exceptional items) margins have improved during Q4FY19. It currently stands at Rs 0.96 crore with an increase from negative EBITDA of Rs. 0.62 crores, in third quarter of the last fiscal year", said Mr. Herlekar.
Shares of OMKAR SPECIALITY CHEMICALS LTD. was last trading in BSE at Rs.8.45 as compared to the previous close of Rs. 8.05. The total number of shares traded during the day was 27076 in over 67 trades.
The stock hit an intraday high of Rs. 8.45 and intraday low of 7.91. The net turnover during the day was Rs. 225157.